Filing Details
- Accession Number:
- 0001144204-10-009473
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-02-23 12:00:00
- Reporting Period:
- 2010-02-12
- Filing Date:
- 2010-02-23
- Accepted Time:
- 2010-02-23 15:13:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1137883 | Brainstorm Cell Therapeutics Inc | BCLI | Biological Products, (No Disgnostic Substances) (2836) | 912061050 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1318693 | David Stolick | C/O Brainstorm Cell Therapeutics Inc. 110 East 59Th Street New York NY 10022 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-02-22 | 100,000 | $0.36 | 150,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sale, and the sales reported on the Form 4 filed on February 19, 2010, were pursuant to a 10b5-1 plan dated October 2009.
Billionaire Hedge Funds
